Long-term use of angiotensin receptor blockers and the risk of cancer.
The association between angiotensin receptor blockers (ARBs) and cancer is controversial with meta-analyses of randomized controlled trials and observational studies reporting conflicting results. Thus, the objective of this study was to determine whether ARBs are associated with an overall increase...
Main Authors: | Laurent Azoulay, Themistocles L Assimes, Hui Yin, Dorothee B Bartels, Ernesto L Schiffrin, Samy Suissa |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2012-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC3521027?pdf=render |
Similar Items
-
The angiotensin II type 2 receptor in cardiovascular disease
by: Catherine A Lemarié, et al.
Published: (2010-03-01) -
Podocyte-Related Mechanisms Underlying Survival Benefit of Long-Term Angiotensin Receptor Blocker
by: Xuejing Zhu, et al.
Published: (2022-05-01) -
Angiotensin receptor blocker add-on therapy in portal hypertension: To use angiotensin receptor blocker or not to use, that is the question
by: Hyun Woong Lee
Published: (2014-12-01) -
Saving lives: Long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
by: Gordon T McInnes
Published: (2000-06-01) -
Saving lives: long-term morbidity and mortality trials with selective angiotensin receptor blocker therapy
by: Gordon T McInnes
Published: (2000-06-01)